| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 07/30/2008 | CN101229285A Hot decocted soup and hot-drink paste preparation for diet-treating gradually happening hiccough and deaf |
| 07/30/2008 | CN101229220A Compound for preventing and curing pseudomyopia and preparing method thereof |
| 07/30/2008 | CN101229166A Therapeutic agent for keratoconjunctival disorder |
| 07/30/2008 | CN100406439C Pyrrolidine derivatives as metalloprotease inhibitors |
| 07/30/2008 | CN100406005C Compound and method for therapeutic intervention in preventing diabetic complications |
| 07/29/2008 | US7405274 Monoclonal antibodies for use in diagnosis and treatment of diabetes, hypertension, hyperglycemia and congestive heart failure |
| 07/29/2008 | US7405192 Difference between the amplified sequence and the normal gene sequence is diagnostic of glaucoma |
| 07/29/2008 | CA2409842C 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |
| 07/29/2008 | CA2401952C Pyranoindoles for treating glaucoma |
| 07/29/2008 | CA2401033C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 07/29/2008 | CA2382322C Aminocarbonyl-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 07/29/2008 | CA2348742C Carbocyclic potassium channel inhibitors |
| 07/29/2008 | CA2333008C New heterocyclically substituted amides, their production and their use |
| 07/29/2008 | CA2218702C Fatty acid esters as bioactive compounds |
| 07/29/2008 | CA2218096C New arylglycinamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds |
| 07/24/2008 | WO2008089015A1 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 07/24/2008 | WO2008088937A1 Quinolynylmethylimidizoles as therapeutic agents |
| 07/24/2008 | WO2008088936A1 Quinolynylmethylimidizoles as therapeutic agents |
| 07/24/2008 | WO2008088612A1 Method of stimulating the production of mucin in the eye of a patient |
| 07/24/2008 | WO2008087933A1 NOVEL INDOLE DERIVATIVE HAVING INHIBITORY ACTIVITY ON IϰB KINASE β |
| 07/24/2008 | WO2008062463A3 Improved process for the preparation of (r)-(+)-4-(ethyiamino)-3,4-dihydro-2-(3- methoxypropyl)-2h-thieno[3,2-e]-l,2-thiazine-6-sulfonamide-l,l-dioxide |
| 07/24/2008 | WO2008021375A3 Modulators of muscarinic receptors |
| 07/24/2008 | WO2008014456A3 Combination therapy for otitis with antiseptic and ph adjustment |
| 07/24/2008 | US20080177082 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 07/24/2008 | US20080177042 Leucine-based motif and clostridial neurotoxins |
| 07/24/2008 | US20080177041 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 07/24/2008 | US20080177037 Leucine-based motif and clostridial neurotoxins |
| 07/24/2008 | US20080176964 Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies |
| 07/24/2008 | US20080176953 Administration of a neuroprotectant( brimonidine, clonidine and para-aminoclonidine) for the treatment of ocular neovascularization (CNV) and macular degeneration; Vision defects; photodynamic therapy; mixture of neuroprotective factor and neovascularization inhibitor |
| 07/24/2008 | US20080176952 Management of Ophthalmologic Disorders, Including Macular Degeneration |
| 07/24/2008 | US20080176847 Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/24/2008 | US20080176795 administering human H3 relaxin, carriers, diluents and/or excipients; anxiolytic agents; hormones |
| 07/24/2008 | US20080175922 Topically treating eye disorders, diseases and inflammation without sensitivity |
| 07/24/2008 | US20080175844 Activin-like receptor kinase immunoglobulin fusion for prevention and treatment of cell proliferative and vision defects; angiogenesis inhibitors |
| 07/24/2008 | US20080175840 Methods for treating angiogenesis related disorders |
| 07/24/2008 | US20080175828 Proliferated cell lines and uses thereof |
| 07/24/2008 | US20080175826 Nutrient broth comprising nervous system and/or ciliary body tissues for identifying modulators of nervous system degeneration; treating vision defects |
| 07/24/2008 | US20080175819 Vector system |
| 07/24/2008 | DE102007002717A1 Heterocyclische Indazolderivate Heterocyclic indazole derivatives |
| 07/24/2008 | CA2674946A1 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 07/24/2008 | CA2674865A1 Indole derivative having i.kappa.b kinase .beta. inhibitory activity |
| 07/23/2008 | EP1947178A1 Human monoclonal antibody binding to human gm-csf and antigen-binding site thereof |
| 07/23/2008 | EP1946765A1 Remedy for angiogenesis-related disease comprising chondromodulin-i as the active ingredient |
| 07/23/2008 | EP1946749A1 Anti-angionene compositions and methods of use |
| 07/23/2008 | EP1945759A1 Resorbable cornea button |
| 07/23/2008 | EP1796628B1 New viscoelastic composition comprising alginate and vitamin e tpgs or tpgsa |
| 07/23/2008 | EP1527781B1 Antipruritic agent |
| 07/23/2008 | EP1420774B1 Preparation and diabetic use of gibberellins |
| 07/23/2008 | EP1412361B1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists |
| 07/23/2008 | EP1372696B1 Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 07/23/2008 | EP1325745B1 Preventives and remedies for complications of diabetes |
| 07/23/2008 | EP1270595B1 Anti ccr4 antibody and its fragment |
| 07/23/2008 | EP1080092B1 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
| 07/23/2008 | EP1073638B1 Heterocyclically substituted amides, their production and their use |
| 07/23/2008 | EP1047416B1 Pharmaceutical compositions comprising disulfiram for inhibiting angiogenesis |
| 07/23/2008 | EP0978284B1 Use of 15-keto-prostaglandin-e compounds as endothelin antagonists |
| 07/23/2008 | CN101228146A Benzofuran derivatives with therapeutic activities |
| 07/23/2008 | CN101227911A Use of spirostenols to treat mitochondrial disorders |
| 07/23/2008 | CN101224281A Chinese traditional medicine preparation for relieving heat and toxins |
| 07/23/2008 | CN100404517C Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof |
| 07/23/2008 | CN100404024C Synergestic combinations comprising renin inhibitor for cardiovascular diseases |
| 07/22/2008 | US7403805 Apparatus and method for noninvasive measurement of analytes from the conjunctiva using mid-infrared radiation |
| 07/22/2008 | US7402696 exert an ACC activity-inhibiting effect that is effective in the treatment of obesity, hyperlipemia, fatty liver, hyperglycemia, impaired glucose tolerance, diabetes, diabetic complications (diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, and diabetic macroangiopathy, hyperten |
| 07/22/2008 | US7402609 Olopatadine formulations for topical administration |
| 07/22/2008 | US7402605 E.g., 17,17-propano-16-hydroxy-5-(4-ethoxycarbonylthiazol-2-yl)-9-oxo-1,2,3,4,20-pentanor-5-thia-8-azaprost-13-ene; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 07/22/2008 | US7402580 Polymerase inhibitors; antiischemic agents; brain disorders; cardiovascular disorders; antiinflammatory agents; antiarthritic agents; neurodegenerative agents; Alzheimer's disease; muscular disorders; antidiabetic agents; kidney disorders; viricides; anticancer agents; immunosuppressants |
| 07/22/2008 | US7402557 Reducing epithelial toxicity such as a skin rash or diarrhea during cancer therapy, by coadministering KGF with erlotinib (N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazoline amine) |
| 07/17/2008 | WO2008086131A1 Naphthylmethylimidizoles as therapeutic agents |
| 07/17/2008 | WO2008085913A1 Methods for treating, preventing, or reducing the risk of opthalmic, otic, and nasal infections |
| 07/17/2008 | WO2008084873A1 Oxime derivative |
| 07/17/2008 | WO2008084872A1 Hydrazone derivative |
| 07/17/2008 | WO2008084574A1 Anti-angiogenic agent |
| 07/17/2008 | WO2008084533A1 Therapeutic agent for meniere’s disease |
| 07/17/2008 | WO2008083513A1 Black soybean hull extract and process for preparation and use thereof |
| 07/17/2008 | WO2008055206A9 Humanized anti-factor d antibodies |
| 07/17/2008 | US20080171882 [(4S)-4-Methyl-2,5-dioxoimidazolidin-4-yl]methanesulfonyl chloride and [(4R)-4-methyl-2,5-dioxoimidazolidin-4-yl]methanesulfonyl chloride; chemical intermediates for enzyme inhibitors |
| 07/17/2008 | US20080171778 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 07/17/2008 | US20080171772 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 07/17/2008 | US20080171072 Ocular inserts containing apomorphine |
| 07/17/2008 | US20080171046 Novel proteins and nucleic acids encoding same |
| 07/17/2008 | DE60130743T2 Mikrokugeln zur aktiven embolisierung Microspheres for embolization active |
| 07/16/2008 | EP1944290A1 Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 07/16/2008 | EP1944034A1 Adsorbent for advanced glycation endproducts |
| 07/16/2008 | EP1944032A2 Biodegradable intraocular implants containing prostamides |
| 07/16/2008 | EP1944024A1 O-substituted aniline derivative and antioxidant drug |
| 07/16/2008 | EP1414431B1 AMINO-ACID-BASED therapeutic COMPOSITIONS, FOR THE HEALING AND/OR MENDING OF WOUNDS AND LESIONS, IN PARTICULAR IN THE OPHTHALMIC FIELD |
| 07/16/2008 | EP1265603B1 Il-8 receptor antagonists |
| 07/16/2008 | CN101220092A Human keratinized cell growth factor-1 analogue preparation method and application thereof |
| 07/16/2008 | CN101220028A Urea substituted imidazopyridines |
| 07/16/2008 | CN101219169A Externally used Chinese medicine for treating prostate gland hyperplasia and delaying human body caducity |
| 07/16/2008 | CN101219145A Quinazoline derivatives as VEGF inhibitors |
| 07/16/2008 | CN101219143A Use of anisodine in preparing medicament for treating amblyopia |
| 07/16/2008 | CN101219100A Medicine film for eyes and production method thereof |
| 07/16/2008 | CN100402528C Urea substituted imidazopyridines |
| 07/16/2008 | CN100402521C 4-imidazolin-2-one compounds |
| 07/16/2008 | CN100402496C Compounds useful as matrix metalloprotease inhibitors |
| 07/16/2008 | CN100402032C Tetrahydroquinoline analogues as muscarinic agonists |
| 07/15/2008 | US7399768 1-methyl-3 beta -hydroxymethyl-6-methoxy-1,2,3,4,4a alpha ,5,10, 10a beta -octahydrobenzo[q]quinoline; decrease on the intraocular pressure; glaucoma and myopia; excellent tolerability, and a long duration of action |
| 07/15/2008 | US7399761 Phthalazine derivatives with angiogenesis inhibiting activity |
| 07/15/2008 | CA2373296C Combination of nicotinic acid or nicotinamide with riboflavin for the treatment of pruritus, itching and inflammation disorders |